Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 2003

View Archived Issues

Improved MRA imaging with MS-325 in the detection of AIOD

Potential applications of ferumoxytol discussed at RSNA 2003

Adherex to acquire noncancer assets from Cadherin Biomedical

ZymoGenetics advances product candidates into clinic in 2003

Phase I study evaluates Aastrom dendritic cell-based vaccine for GI cancers

Bionomics and Brigham & Women's collaborate to identify epilepsy genes

CytoGenix ssDNA technology to be evaluated against bacterial sepsis

Orphan drug designation for DX-890 for cystic fibrosis

Pariet submitted for ZES and pathological hypersecretory conditions in Europe

GMP Companies collaborates with U. of Michigan on benzodiazepine technology

Phase I trial of topotecan TCS delayed until Q3 2004

New agreement to develop PLD-177 with Clickhaler technology

New PDE5 inhibitors reported by SK Chemicals and In2Gen team

Another series of GABA-A receptor modulators identified by Neurogen researchers

Novel 5-HT4 agonist with good safety profile and its use in GI motility disorders

Inhibitors of IL-12 production prepared and tested at Taisho

Schering AG patent covers new iNOS inhibitors and their use

CC-5013 safe and effective in hematological malignancies

Clioquinol slows rate of cognitive decline in Alzheimer's disease

Antitumor effects of CCI-779 in multiple myeloma and MCL

Efficacy and safety of lonafarnib in hematological tumors

Cytopia and Myomatrix collaborate in cardiovascular disease

COMBAT study to assess dutasteride plus tamsulosin for BPH

GTC takes equity position in Merrimack under amended MM-093 agreement

SomatoKine granted orphan drug designation for extreme insulin resistance

Investigators meeting precedes phase III Xerecept program

Xenical approved for obese adolescents

Sosei and Nippon Organon to copromote SOT-375 in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.